AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2023
Mar 3, 2023
29777_dirs_2023-03-02_e844e3d8-624e-49d1-947a-a88cbab760e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2023-02-28
Reporting Person: Wellisch Alejandro D (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-28 | Common shares without par value | A | 10650 | — | Acquired | 50482 | Direct |
| 2023-02-28 | Common shares without par value | F | 3730 | $99.77 | Disposed | 46752 | Direct |
Footnotes
F1: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25